Featured White Papers
- Oct. 14th: Simplified IT with Software-as-a-Service (SaaS) (ZDNet)
- PCI DSS therapy for the smaller retailer (McAfee)
- Recognizing the benefits of telework (Citrix Online)
Technology Industry
Industry: Email Alert RSS FeedPozen Inc
BT Catalyst, Dec, 1999
Pozen Inc. of Chapel Hill has acquired an exclusive worldwide license to a novel serotonin receptor antagonist discovered by F. Hoffmann-La Roche Ltd. of Basel, Switzerland. The compound is being developed as a migraine prophylactic agent.
COPYRIGHT 1999 North Carolina Biotechnology Center
COPYRIGHT 2008 Gale, Cengage Learning